Treatment strategy for hepatocellular carcinoma in China: radiofrequency ablation versus liver resection.
Hepatocellular carcinoma is the most common malignancy in liver, is also a global problem and is the fourth most commonly diagnosed cancers among men and the fourth leading causes of cancer death among both men and women in China. Liver resection or hepatic resection and radiofrequency ablation is widely accepted as a first-line surgical approach for hepatocellular carcinoma in China. However, the indications of radiofrequency ablation or hepatic resection are different and not unified in China. In this article, we review the current status of hepatic resection and radiofrequency ablation therapies in hepatocellular carcinoma management in China.
Liver Transplantation Division, Department of Liver Surgery, West China Hospital, Sichuan University, Chengdu, China.
Ze-Xin
ZX
Zhu
Liver Transplantation Division, Department of Liver Surgery, West China Hospital, Sichuan University, Chengdu, China.
Ji-Wei
JW
Huang
Liver Transplantation Division, Department of Liver Surgery, West China Hospital, Sichuan University, Chengdu, China.
Ming-Heng
MH
Liao
Liver Transplantation Division, Department of Liver Surgery, West China Hospital, Sichuan University, Chengdu, China zengyong@medmail.com.cn.
Yong
Y
Zeng
D006528:Carcinoma, Hepatocellular / Q000473:pathology / Q000601:surgery / Q000628:therapy*; D017115:Catheter Ablation; D002681:China; D006498:Hepatectomy; D006801:Humans; D008113:Liver Neoplasms / Q000473:pathology / Q000601:surgery / Q000628:therapy*; D016896:Treatment Outcome
China; hepatic resection (HR); hepatocellular carcinoma (HCC); liver resection (LR); radiofrequency ablation (RFA)